Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone replacement can help menopausal women with various symptoms, but should be used carefully and is not yet officially licensed in the UK for women.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.

Glibenclamide slows breast cancer cell growth by stopping cell division.

The number of advanced breast cancer cases in women under 40 has increased, but the overall numbers are still low.

Including androgens in hormone therapy may lower breast cancer risk.

Steroid sex hormones activate matriptase in prostate cancer cells but not in breast cancer cells.

Reproductive hormones play a crucial role in breast cancer development and treatment challenges.

No definitive link between finasteride and male breast cancer, but further research is needed.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

Sacituzumab Govitecan is effective for certain breast cancers but requires careful management of side effects.

Breast cancer hormone therapy can cause hair loss, which can be treated with daily applications of specific topical solutions like minoxidil and hydrocortisone butyrate.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

ATP-sensitive K+ channel subunits, particularly Sur2A, play a significant role in various cancers.

Blood tests for tumor cells could improve prostate cancer diagnosis and treatment; hair loss severity linked to a gene affecting prostate conditions.

The document concludes that sex hormones and related compounds have various effects on health, with both potential benefits and risks.

Managing side effects of endocrine therapy is crucial to improve adherence and survival in breast cancer patients.

Consult an oncologist before using supplements for hair loss during breast cancer treatment.

Hair loss from hormone therapy in breast cancer patients can be improved with minoxidil treatment.

Abemaciclib can cause skin, hair, and nail problems, leading some patients to stop using it.

Genetic counselors should be culturally skilled and aware of transgender patients' unique health risks and needs.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

The document concludes that health care providers should offer culturally competent care and more research is needed to improve health outcomes for transgender individuals.

Gender-affirming hormone therapy improves mental health and gender incongruence but requires careful management of cardiovascular and cancer risks.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Capivasertib improves survival in certain breast cancer cases but requires careful management of side effects.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

Small hormonal imbalances can cause significant health problems, so more sensitive testing for hormone-disrupting chemicals is needed.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.